-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Anchor targets, ensure strategic implementation! Keyuan Pharmaceutical holds its 2025 Annual Target Communication and Implementation Meeting!
Publish Time:
2025-01-14
The successful convening of this year's 2025 Annual Target Promotion and Implementation Meeting marks a solid step forward for Keyuan Pharmaceutical in planning and executing its strategic goals for 2025. By clarifying the direction, establishing clear guidelines, defining specific measures, and strengthening execution, the company has laid a robust foundation for smoothly advancing subsequent tasks—and ensuring that it achieves a strong start to both the first month and the first quarter!
A new journey gives rise to a new mission, and a new mission calls for fresh actions. Recently, Keyuan Pharmaceutical (stock code: 301281.SZ) grandly held its 2025 Target Implementation Conference, providing a comprehensive overview of the 2025 targets and tasks. The company urged all employees to stay firmly focused on their goals, maintain unwavering confidence, press forward under pressure, and bravely take responsibility—working together with full dedication to achieve a strong start in the first month and the first quarter. Senior management, heads of various departments, and core team members attended the event.
Metrics are commands; performance is dignity.
The meeting emphasized that targets are commands, and performance is a matter of dignity—so we must ensure their complete and unwavering fulfillment! Heads of each department are tasked with thoroughly communicating and clearly breaking down the targets within their respective teams, ensuring full coverage both horizontally and vertically. These goals must be rolled out to every single department and individual, down to the smallest detail—and scheduled on a monthly and weekly basis. Ultimately, every employee becomes not just a recipient but also the accountable party responsible for these specific targets, committing themselves fully to deliver results with absolute determination.
Strengthen execution capabilities, enhance learning agility
The meeting emphasized that strengthening execution is the key to achieving our targets. Execution reflects attitude—every employee must maintain a firm, optimistic mindset, refusing to give up until the goal is reached. When challenges arise, we should act swiftly, avoiding procrastination or avoidance, and responding with agility. At the same time, we must continuously enhance our ability to solve problems effectively, ensuring that tasks are thoroughly and comprehensively addressed—leaving no room for superficiality, empty showmanship, or half-hearted efforts. Additionally, we need to bolster our capacity for continuous learning, applying what we’ve learned creatively and innovatively to meet the ever-growing demands of our business.
Increase R&D investment and forge a strong technical team.
The meeting clearly emphasized that the company should increase its investment in R&D, strengthen collaboration with universities and research institutions, and jointly develop cutting-edge technologies tailored to key industry areas—thereby continuously enhancing the company’s technological capabilities. At the same time, the company must focus on cultivating and nurturing a skilled technical team that is ready to tackle challenges, deliver results, and achieve victory, ensuring rapid commercialization of innovative technologies and effectively stockpiling "ammunition" for the company’s long-term growth and success.
Leverage existing strengths and strengthen brand development.
The meeting emphasized that Keyuan Pharmaceutical should continue to leverage its competitive advantages in integrated raw material and formulation production, as well as integrated excipient and formulation development. Guided by technological innovation and R&D, the company is encouraged to strengthen its marketing team, enhance brand-building efforts, and boost product awareness and reputation—ultimately helping to expand market share further. At the same time, Keyuan must remain steadfast in its internationalization strategy, relentlessly striving toward the goal of becoming a world-class pharmaceutical enterprise.
The successful convening of this year's 2025 Annual Target Promotion and Implementation Meeting marks a solid step forward for Keyuan Pharmaceutical in planning and executing its strategic objectives for 2025. By clarifying the direction, establishing clear guidelines, defining actionable measures, and strengthening execution, the meeting has laid a robust foundation for the smooth progression of all subsequent initiatives—ensuring the company achieves a strong start to both the first month and the first quarter!
Latest News
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline